Shortcuts
Thiols
Disulfides
Silanes
MOFs
Graphene derivatives
Nanoparticles
News
Igeneer kit - a new product resulting from the Igene project
The I·Gene technology and the following I·Geneer Kit offers a rationally designed approach for highly specific and precise genome editing tool at the in vitro level.
Molecular Thermometer - newly published proceedings based on ProChimia Surfaces Nanomaterial
As a part of fruitful I-GENE project research the measurement of temperature-dependent fluorescence were investigated. Here we report the exploration of new molecular thermometer and its reversible optical proporties.
ProChimia is presenting the I-Gene concept and proceedings on Xth National Nanotechnology Conference in July'22, POLAND
The I-Gene concept of programmable edditing of genomes and latest results will be presented to the Polish nanotechnology community united on the Krajowa Konferencja Nanotechnologiczna 3-8 July, held in Kraków, Poland
4th issue of the I-GENE newsletter.
Dear Readers, The I-GENE team is pleased to welcome you to the 4th issue of the I-GENE newsletter.
Come and hear about how we can advance the use of nanoparticles and evolutionary AI in cancer therapies.
Join the Evo Nano team to hear about our evolvable platform for programmable nanoparticle-based cancer therapies
New article about the promising results of our work on the EVO-Nano project
EU-backed researchers build state-of-the-art software that harnesses AI to design nanomedicine that fights cancer cells.
EVO-NANO in silico news!
Our valued colleagues from EVO-NANO project in silico group published on-line their newest research on multi type NPs anticancer therapies …
Specific and long-lasting mitochondrial targeting via mixed-charged nanocarriers.
Mixed charged functionalised gold nanoparticles proved to serve as efficient organelle specific delivery vehicles!
Nanomedicine for gene therapy!
The school will provide an overview of the use CRISPR/Cas9 technique as a powerful tool for gene editing.
Metameric representations on optimization of nano particle cancer treatment
Members of the EVONANO consortium (University of Novi Sad and University of the West of England) have published most recently the results on the in silico optimization of multi component cancer nanotherapies.
I-gene project has been analysed by the European Commission's Innovation Radar.
It was identify as Business Ready (Market Maturity of the Innovation) and the potential of the innovation is very high
Join the workshop HOW CAN NANOMEDICINE BE USED FOR PRECISE GENOME EDITING? 11-13 November 2020.
Prochimia Surfaces and their colleagues from the I-gene project are honored to invite all interested parties to the training school.
ProChimia manufactured multi-sulfonated ligands on gold nanoparticles are virucidal to Dengue virus - Nature Scientific Report available Now !
Our wide collaboration Scienfic Report on ProChimia's multi sulphonated ligands has been published on June 2020 by Nature
Mixed charge Gold Nanoparticles - prooven deadly weapon against cancer cells !
AuNPs charged by our ionized ligands has been just shown to exhibit anticancer activity leading selectively to death of cancerous cells.
Prochimia Surfaces is a part of the I-Gene project (In-vivo Gene Editing by NanotransducErs) granted by the EU Horizon 2020 research and innovation programme!!!!
I-GENE is a technique to erase harmful mutations in genetic diseases.
Thiolated carbohydrates (mimmicing glycans)
ProChimia Surfaces is proud to present new category of our products
Ultra-bioresistant Zwitterionic ligands now available on our website !
A new class of thiolated ligands exhibiting the ultra non-fouling properties has been intorduced to our product portfolio
Prochimia Surfaces is a part of the EVO-NANO project (Evolvable platform for programmable nanoparticle-based cancer therapies.) granted by the EU Horizon 2020 research and innovation programme!!!!
Read more http://evonano.eu
Info
Polish version of price list, sale conditions and terms and Privacy Policy are available for download as PDF files below:
Price list
Sale conditions and terms